Jump to content

User:Immcarle110/Anti-SSA/Ro autoantibodies/Bibliography

From Wikipedia, the free encyclopedia

Bibliography

[edit]

[1] Nair, Jisha J.; Singh, Tejas P. (2017-04). "Sjogren's syndrome: Review of the aetiology, Pathophysiology & Potential therapeutic interventions". Journal of Clinical and Experimental Dentistry. 9 (4): e584–e589. doi:10.4317/jced.53605. ISSN 1989-5488. PMC 5410683. PMID 28469828

[2] Brito-Zerón, Pilar; Ramos-Casals, Manuel; EULAR-SS task force group (2014-09). "Advances in the understanding and treatment of systemic complications in Sjögren's syndrome". Current Opinion in Rheumatology. 26 (5): 520–527. doi:10.1097/BOR.0000000000000096. ISSN 1531-6963. PMID 25050925

[3] ( Re-visit) Rhodes, David A.; Isenberg, David A. (12 2017). "TRIM21 and the Function of Antibodies inside Cells". Trends in Immunology. 38 (12): 916–926. doi:10.1016/j.it.2017.07.005. ISSN 1471-4981. PMID 28807517



Here down: read

[4] Gleicher, Norbert; Elkayam, Uri (2013-09). "Preventing congenital neonatal heart block in offspring of mothers with anti-SSA/Ro and SSB/La antibodies: a review of published literature and registered clinical trials". Autoimmunity Reviews. 12 (11): 1039–1045. doi:10.1016/j.autrev.2013.04.006. ISSN 1873-0183. PMID 23684701

[5] (DONE - there is much more tho) Yoshimi, Ryusuke; Ueda, Atsuhisa; Ozato, Keiko; Ishigatsubo, Yoshiaki (2012). "Clinical and Pathological Roles of Ro/SSA Autoantibody System". Clinical and Developmental Immunology. 2012. doi:10.1155/2012/606195. ISSN 1740-2522. PMC 3523155. PMID 23304190.

[6] (Done) Oke, Vilija; Wahren-Herlenius, Marie (2012-08-01). "The immunobiology of Ro52 (TRIM21) in autoimmunity: A critical review". Journal of Autoimmunity. Special Issue: Current pathogenetic, clinical and therapeutic aspects of Sjögren's syndrome. 39 (1): 77–82. doi:10.1016/j.jaut.2012.01.014. ISSN 0896-8411 [7] (Meh) Ma, Kongyang; Du, Wenhan; Wang, Xiaohui; Yuan, Shiwen; Cai, Xiaoyan; Liu, Dongzhou; Li, Jingyi; Lu, Liwei (2019-11-29). "Multiple Functions of B Cells in the Pathogenesis of Systemic Lupus Erythematosus". International Journal of Molecular Sciences. 20 (23). doi:10.3390/ijms20236021. ISSN 1422-0067. PMC 6929160. PMID 31795353.

[8] (Done) Izmirly, Peter; Saxena, Amit; Buyon, Jill P. (2017-9). "Progress in the pathogenesis and treatment of cardiac manifestations of neonatal lupus". Current opinion in rheumatology. 29 (5): 467–472. doi:10.1097/BOR.0000000000000414. ISSN 1040-8711. PMC 5578407. PMID 28520682

[9] McMahon, Maureen; Kalunian, Kenneth (2005-01-01), Lotze, Michael T.; Thomson, Angus W. (eds.), "Chapter 17 - SLE-Associated Tests", Measuring Immunity, Academic Press, pp. 210–220, ISBN 978-0-12-455900-4, retrieved 2020-02-28

[10] Keogan, Mary; Kearns, Grainne; Jefferies, Caroline A. (2011-01-01), Lahita, Robert G. (ed.), "Chapter 15 - Extractable Nuclear Antigens and SLE: Specificity and Role in Disease Pathogenesis", Systemic Lupus Erythematosus (Fifth Edition), Academic Press, pp. 259–274, ISBN 978-0-12-374994-9, retrieved 2020-02-28

[11] Dutz, Jan P. (2013-01-01), Wallace, Daniel J.; Hahn, Bevra Hannahs (eds.), "Chapter 23 - Pathomechanisms of Cutaneous Lupus Erythematosus", Dubois' Lupus Erythematosus and Related Syndromes (Eighth Edition), W.B. Saunders, pp. 310–318, ISBN 978-1-4377-1893-5, retrieved 2020-02-28

[12] Reichlin, MORRIS; Scofield, R. HAL (2007-01-01), Shoenfeld, Yehuda; Gershwin, M. Eric; Meroni, Pier Luigi (eds.), "30 - SS-A (Ro) AUTOANTIBODIES", Autoantibodies (Second Edition), Elsevier, pp. 225–230, ISBN 978-0-444-52763-9, retrieved 2020-02-28

[13] Reeves, Westley H.; Li, Yi; Zhuang, Haoyang (2015-01-01), Hochberg, Marc C.; Silman, Alan J.; Smolen, Josef S.; Weinblatt, Michael E. (eds.), "130 - Autoantibodies in systemic lupus erythematosus", Rheumatology (Sixth Edition), Content Repository Only!, pp. 1074–1081, ISBN 978-0-323-09138-1, retrieved 2020-02-28

[14] Hervier, Baptiste; Rimbert, Marie; Colonna, Francoise; Hamidou, Mohammed A.; Audrain, Marie (2009-08-01). "Clinical significance of anti-Ro/SSA-52 kDa antibodies—a retrospective monocentric study". Rheumatology. 48 (8): 964–967. doi:10.1093/rheumatology/kep145. ISSN 1462-0324.

[15] [NOT A REVIEW] Gkoutzourelas, Athanasios; Liaskos, Christos; Mytilinaiou, Maria G.; Simopoulou, Theodora; Katsiari, Christina; Tsirogianni, Alexandra; Daoussis, Dimitrios; Scheper, Thomas; Meyer, Wolfgang; Bogdanos, Dimitrios P.; Sakkas, Lazaros I. (2018-12-07). "Anti-Ro60 Seropositivity Determines Anti-Ro52 Epitope Mapping in Patients With Systemic Sclerosis". Frontiers in Immunology. 9. doi:10.3389/fimmu.2018.02835. ISSN 1664-3224. PMC 6293197. PMID 30581434.

[16] [NOT A REVIEW] Burbelo, Peter D.; Teos, Leyla Y.; Herche, Jesse L.; Iadarola, Michael J.; Alevizos, Ilias (2018-02-20). "Autoantibodies against the Immunoglobulin-Binding Region of Ro52 Link its Autoantigenicity with Pathogen Neutralization". Scientific Reports. 8. doi:10.1038/s41598-018-21522-7. ISSN 2045-2322. PMC 5820281. PMID 29463848.

  1. ^ Nair, Jisha J.; Singh, Tejas P. (2017-04). "Sjogren's syndrome: Review of the aetiology, Pathophysiology & Potential therapeutic interventions". Journal of Clinical and Experimental Dentistry. 9 (4): e584–e589. doi:10.4317/jced.53605. ISSN 1989-5488. PMC 5410683. PMID 28469828. {{cite journal}}: Check date values in: |date= (help)
  2. ^ Brito-Zerón, Pilar; Ramos-Casals, Manuel; EULAR-SS task force group (2014-09). "Advances in the understanding and treatment of systemic complications in Sjögren's syndrome". Current Opinion in Rheumatology. 26 (5): 520–527. doi:10.1097/BOR.0000000000000096. ISSN 1531-6963. PMID 25050925. {{cite journal}}: Check date values in: |date= (help)
  3. ^ Rhodes, David A.; Isenberg, David A. (12 2017). "TRIM21 and the Function of Antibodies inside Cells". Trends in Immunology. 38 (12): 916–926. doi:10.1016/j.it.2017.07.005. ISSN 1471-4981. PMID 28807517. {{cite journal}}: Check date values in: |date= (help)
  4. ^ Gleicher, Norbert; Elkayam, Uri (2013-09). "Preventing congenital neonatal heart block in offspring of mothers with anti-SSA/Ro and SSB/La antibodies: a review of published literature and registered clinical trials". Autoimmunity Reviews. 12 (11): 1039–1045. doi:10.1016/j.autrev.2013.04.006. ISSN 1873-0183. PMID 23684701. {{cite journal}}: Check date values in: |date= (help)
  5. ^ Yoshimi, Ryusuke; Ueda, Atsuhisa; Ozato, Keiko; Ishigatsubo, Yoshiaki (2012). "Clinical and Pathological Roles of Ro/SSA Autoantibody System". Clinical and Developmental Immunology. 2012. doi:10.1155/2012/606195. ISSN 1740-2522. PMC 3523155. PMID 23304190.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  6. ^ Oke, Vilija; Wahren-Herlenius, Marie (2012-08-01). "The immunobiology of Ro52 (TRIM21) in autoimmunity: A critical review". Journal of Autoimmunity. Special Issue: Current pathogenetic, clinical and therapeutic aspects of Sjögren's syndrome. 39 (1): 77–82. doi:10.1016/j.jaut.2012.01.014. ISSN 0896-8411.
  7. ^ Ma, Kongyang; Du, Wenhan; Wang, Xiaohui; Yuan, Shiwen; Cai, Xiaoyan; Liu, Dongzhou; Li, Jingyi; Lu, Liwei (2019-11-29). "Multiple Functions of B Cells in the Pathogenesis of Systemic Lupus Erythematosus". International Journal of Molecular Sciences. 20 (23). doi:10.3390/ijms20236021. ISSN 1422-0067. PMC 6929160. PMID 31795353.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  8. ^ Izmirly, Peter; Saxena, Amit; Buyon, Jill P. (2017-9). "Progress in the pathogenesis and treatment of cardiac manifestations of neonatal lupus". Current opinion in rheumatology. 29 (5): 467–472. doi:10.1097/BOR.0000000000000414. ISSN 1040-8711. PMC 5578407. PMID 28520682. {{cite journal}}: Check date values in: |date= (help)
  9. ^ McMahon, Maureen; Kalunian, Kenneth (2005-01-01), Lotze, Michael T.; Thomson, Angus W. (eds.), "Chapter 17 - SLE-Associated Tests", Measuring Immunity, Academic Press, pp. 210–220, ISBN 978-0-12-455900-4, retrieved 2020-02-28
  10. ^ Keogan, Mary; Kearns, Grainne; Jefferies, Caroline A. (2011-01-01), Lahita, Robert G. (ed.), "Chapter 15 - Extractable Nuclear Antigens and SLE: Specificity and Role in Disease Pathogenesis", Systemic Lupus Erythematosus (Fifth Edition), Academic Press, pp. 259–274, ISBN 978-0-12-374994-9, retrieved 2020-02-28
  11. ^ Dutz, Jan P. (2013-01-01), Wallace, Daniel J.; Hahn, Bevra Hannahs (eds.), "Chapter 23 - Pathomechanisms of Cutaneous Lupus Erythematosus", Dubois' Lupus Erythematosus and Related Syndromes (Eighth Edition), W.B. Saunders, pp. 310–318, ISBN 978-1-4377-1893-5, retrieved 2020-02-28
  12. ^ Reichlin, MORRIS; Scofield, R. HAL (2007-01-01), Shoenfeld, Yehuda; Gershwin, M. Eric; Meroni, Pier Luigi (eds.), "30 - SS-A (Ro) AUTOANTIBODIES", Autoantibodies (Second Edition), Elsevier, pp. 225–230, ISBN 978-0-444-52763-9, retrieved 2020-02-28
  13. ^ Reeves, Westley H.; Li, Yi; Zhuang, Haoyang (2015-01-01), Hochberg, Marc C.; Silman, Alan J.; Smolen, Josef S.; Weinblatt, Michael E. (eds.), "130 - Autoantibodies in systemic lupus erythematosus", Rheumatology (Sixth Edition), Content Repository Only!, pp. 1074–1081, ISBN 978-0-323-09138-1, retrieved 2020-02-28
  14. ^ Hervier, Baptiste; Rimbert, Marie; Colonna, Francoise; Hamidou, Mohammed A.; Audrain, Marie (2009-08-01). "Clinical significance of anti-Ro/SSA-52 kDa antibodies—a retrospective monocentric study". Rheumatology. 48 (8): 964–967. doi:10.1093/rheumatology/kep145. ISSN 1462-0324.
  15. ^ Gkoutzourelas, Athanasios; Liaskos, Christos; Mytilinaiou, Maria G.; Simopoulou, Theodora; Katsiari, Christina; Tsirogianni, Alexandra; Daoussis, Dimitrios; Scheper, Thomas; Meyer, Wolfgang; Bogdanos, Dimitrios P.; Sakkas, Lazaros I. (2018-12-07). "Anti-Ro60 Seropositivity Determines Anti-Ro52 Epitope Mapping in Patients With Systemic Sclerosis". Frontiers in Immunology. 9. doi:10.3389/fimmu.2018.02835. ISSN 1664-3224. PMC 6293197. PMID 30581434.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  16. ^ Burbelo, Peter D.; Teos, Leyla Y.; Herche, Jesse L.; Iadarola, Michael J.; Alevizos, Ilias (2018-02-20). "Autoantibodies against the Immunoglobulin-Binding Region of Ro52 Link its Autoantigenicity with Pathogen Neutralization". Scientific Reports. 8. doi:10.1038/s41598-018-21522-7. ISSN 2045-2322. PMC 5820281. PMID 29463848.
Retrieved from "https://wiki.riteme.site/w/index.php?title=User:Immcarle110/Anti-SSA/Ro_autoantibodies/Bibliography&oldid=944264948"